A systematic review of 29,941 patients shows that preoperative MRI findings significantly improve risk stratification for men with prostate cancer undergoing radical prostatectomy.

Prostate cancer kills more than 12,000 men a year in the UK, slightly more than the number of women who die from breast cancer.

Lucida Medical has raised £8.7m to power its ‘same-day’ cancer diagnosis. IW Capital has invested in the Cambridge healthtech ...

Lucida’s software is designed to identify prostate cancer ‘within minutes’ and overcome diagnosis delays associated with ...

The campaign for better prostate cancer awareness has provoked important questions about the lack of testing and screening. Why are men dying unnecessarily?

Leading figures from the world of business and sport, including Sir Chris Hoy and Sir Tom Hunter, have urged tens of ...

​A prostate cancer diagnosis turned life upside down for Lisburn man Stuart Rainey, bringing fear, uncertainty and countless ...

Men don’t have to die from prostate cancer. It’s a matter of making them aware. When I first found out about it, and that this is a cancer that can be ...

And it's poised to now offer even more data. Prenuvo is launching a new bloodwork component to complement its full-body MRI ...

'The more men who get tested, the better' ...

"I was 46 when I was diagnosed, I remember it was my birthday." ...

Test Now Incorporates Enhanced Machine Learning Risk Prediction Algorithm Plans Underway to Commercialise Testing Service Through Trinity Biotech’s New York Reference Laboratory DUBLIN and NEW YORK, ...